# AbCellera Biologics Inc. (ABCL) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$217M |
| 2024 | -$315M |
| 2023 | -$237M |
| 2022 | $217M |
| 2021 | $204M |
| 2020 | $156M |
| 2019 | -$4M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$58M |
| 2025-09-30 | -$76M |
| 2025-06-30 | -$50M |
| 2025-03-31 | -$63M |
| 2024-09-30 | -$94M |
| 2024-06-30 | -$93M |
| 2024-03-31 | -$55M |
| 2023-09-30 | -$55M |
| 2023-06-30 | -$51M |
| 2023-03-31 | -$65M |
| 2022-09-30 | $38M |
| 2022-06-30 | -$8M |
| 2022-03-31 | $225M |
| 2021-09-30 | -$28M |
| 2021-06-30 | -$7M |
| 2021-03-31 | $158M |
| 2020-09-30 | -$2M |
| 2020-06-30 | -$854,000 |
| 2020-03-31 | -$2M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ABCL/operating-income)